A study recently published in the medical journal Lancet suggests that anti-smoking cessation drugs like varenicline and bupropion are now considered safe by experts in a large international research commissioned by FDA. The two drugs, marketed as Pfizer’s Chantix and GlaxoSmithKline’s Zyban, are extremely restricted due to ‘Black Box Warning’ printed on their labels.
A study on stroke victims claims that the insular cortex of the brain can be targeted to help smokers quit without experiencing severe withdrawal.
